Detalles de la búsqueda
1.
Exposure-response relationships for the efficacy and safety of filgotinib and its metabolite GS-829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies.
Br J Clin Pharmacol
; 88(7): 3211-3221, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35072287
2.
Population pharmacokinetics and exposure-response of osimertinib in patients with non-small cell lung cancer.
Br J Clin Pharmacol
; 83(6): 1216-1226, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28009438
3.
Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects.
Int J Clin Pharmacol Ther
; 51(3): 187-99, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23357841
4.
Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study.
Br J Clin Pharmacol
; 72(2): 270-81, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21392075
5.
Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups.
Clin Transl Sci
; 12(2): 151-163, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30221827
Resultados
1 -
5
de 5
1
Próxima >
>>